Dis-Chem Pharmacies Limited reported revenue results for the period from 1 September 2022 to 5 February 2023. For the period, the company recorded group revenue growth (excluding vaccines and COVID-19 related lines) of 8.7% compared to the corresponding period in the prior year ("corresponding period").
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.54 ZAR | +5.62% | +4.63% | +6.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.03% | 1.49B | |
-32.21% | 15.27B | |
-29.67% | 10.84B | |
-28.54% | 6.06B | |
+8.14% | 6.04B | |
-11.41% | 5.86B | |
-1.17% | 4.69B | |
+52.19% | 4.29B | |
-14.86% | 3.33B | |
-6.93% | 3.01B |
- Stock Market
- Equities
- DCP Stock
- News Dis-Chem Pharmacies Limited
- Dis-Chem Pharmacies Limited Reports Revenue Results for the Period from 1 September 2022 to 5 February 2023